Landon Kristen 4

4 · 60 DEGREES PHARMACEUTICALS, INC. · Filed Aug 14, 2025

Insider Transaction Report

Form 4
Period: 2025-01-17
Landon Kristen
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2025-01-17+4,5404,540 total
Footnotes (2)
  • [F1]This Form 4 is being filed late due to an inadvertent administrative error.
  • [F2]The number of shares has been adjusted to reflect the 1-for-5 reverse stock split effected by the Issuer on February 24, 2025.

Documents

1 file
  • 4
    ownership.xmlPrimary